Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 9/20 | 0.42 |
| ▸ | TRAP1 | Q12931 | 2/20 | 0.38 |
| ▸ | SNCA | P37840 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL2971315 | 0.93 | HIF1A (0.58) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL2446042 | 0.85 | HIF1A (0.74) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL2449969 | 0.85 | HIF1A (0.74) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL3391859 | 0.83 | HIF1A (0.70) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL2450121 | 0.83 | HIF1A (0.70) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL7634128 | 0.83 | HIF1A (0.70) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL4184421 | 0.83 | HIF1A (0.70) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL52420 | 0.83 | HIF1A (0.70) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL8761335 | 0.83 | HIF1A (0.70) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| SCHEMBL31146915 | 0.83 | HIF1A (0.78) | HIF1AALDH1A1CYP1A2CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8524193-B2 | Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts | THE JOHNS HOPKINS UNIVERSITY (US) | 2013-09-03 | — | — | US | disclosed |
| CN-101838289-A | Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts | UNIV JOHNS HOPKINS | 2010-09-22 | — | — | CN | disclosed |
| CN-100577213-C | Non-invasive diagnostic imaging technique for mitochondrial dysfunction using radioisotope labeled lipophilic salts | UNIV JOHNS HOPKINS | 2010-01-06 | — | — | CN | disclosed |
| US-7112318-B2 | Phosphonium or quaternary ammonium salts labeled with 11C, 18F,76Br, or 123I; for positron emission tomography; capable of measuring mitochondrial surface potential; localize into dysfunctional mitochondria | THE JOHNS HOPKINS UNIVERSITY (US) | 2006-09-26 | — | — | US | disclosed |
| US-20050182027-A1 | radiolabeled phosphonium or ammonium salts that accumulate in mitochondria of cancer cells; cancer diagnosis; tomography; distinguishes between tissue inflammation and tumors; e.g. F18-3-fluoropropyltriphenyl phosphonium bromide | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-08-18 | — | — | US | disclosed |
| CN-1627962-A | Non-invasive diagnostic imaging technique for mitochondrial dysfunction using radioisotope labeled lipophilic salts | UNIV JOHNS HOPKINS (US) | 2005-06-15 | — | — | CN | disclosed |
| EP-1474177-A2 | NON-INVASIVE DIAGNOSTIC IMAGING TECHNOLOGY FOR MITOCHONDRIA USING RADIOLABELED LIPOPHILIC SALTS | The John Hopkins University (US) | 2004-11-10 | — | — | EP | disclosed |
| US-20040033197-A1 | Phosphonium or quaternary ammonium salts labeled with 11C, 18F,76Br, or 123I; for positron emission tomography; capable of measuring mitochondrial surface potential; localize into dysfunctional mitochondria | THE JOHNS HOPKINS UNIVERSITY (US) | 2004-02-19 | — | — | US | disclosed |
| WO-2003065882-A2 | NON-INVASIVE DIAGNOSTIC IMAGING TECHNOLOGY FOR MITOCHONDRIA USING RADIOLABELED LIPOPHILIC SALTS | THE JOHNS HOPKINS UNIVERSITY (US) | 2003-08-14 | — | — | WO | disclosed |
| EP-0679707-B1 | Liquid crystalline compound, liquid crystal composition and liquid crystal display element | CHISSO CORP (JP) | 1999-06-16 | — | — | EP | disclosed |
| US-5720899-A | Liquid crystalline compound, liquid crystal composition and liquid crystal display element | CHISSO CORPORATION (JP) | 1998-02-24 | — | — | US | disclosed |
| US-5653911-A | Liquid crystalline compound liquid crystal composition and liquid crystal display element | CHISSO CORPORATION (JP) | 1997-08-05 | — | — | US | disclosed |
| EP-0679707-A1 | Liquid crystalline compound, liquid crystal composition and liquid crystal display element | Chisso Corporation (JP) | 1995-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182027-A1 | radiolabeled phosphonium or ammonium salts that accumulate in mitochondria of cancer cells; cancer diagnosis; tomography; distinguishes between tissue inflammation and tumors; e.g. F18-3-fluoropropyltriphenyl phosphonium bromide | SLC8B1, TFAM, MT-ATP8 | HIF1A 600/4885ALDH1A1 4697/4885CYP1A2 4427/4885 |
| US-20040033197-A1 | Phosphonium or quaternary ammonium salts labeled with 11C, 18F,76Br, or 123I; for positron emission tomography; capable of measuring mitochondrial surface potential; localize into dysfunctional mitochondria | ATP5PB, MCU, ATP5PD | HIF1A 691/4885ALDH1A1 3981/4885CYP1A2 3787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.